ioneer IONR 深 沪
等待开盘 09-22 09:30:00 美东时间
3.25
-0.180
-5.25%
华盛通- 最 高3.315
- 今 开3.28
- 成交量 6.60万股
- 最 低 3.19
- 昨 收 3.43
- 总市值 2.46亿
- 52周最高 8.20
- 市盈率 静 --
- 换手率 0.09%
- 52周最低 2.79
- 委 比 64.94%
- 总股本 7582.78万
- 历史最高 24.00
- 量 比 0.55
- 振 幅 3.64%
- 历史最低 2.30
- 每 手 1
- 风险率 0.87%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
Telix Pharmaceuticals has signed a strategic merger agreement with ITM Isotope Technologies Munich, a global leader in radioisotope production. The merger aims to enhance Telix's capabilities in radiopharmaceutical development, isotope production, and global manufacturing. ITM brings expertise in lutetium-177, actinium-225, and terbium-161 production, with ITM-11, a novel therapeutic candidate for neuroendocrine tumors, completing Phase 3 develop...
09-21 00:55
Big Tech’s $300B AI guarantees raise hidden risk for investors
Technology companies have provided as much as $300 billion in guarantees to finance artificial intelligence data centers and chips during the past year, helping support the construction boom without i...
09-20 21:14
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics granted stock options for 52,834 shares and 35,025 RSUs to 23 employees hired in August and September 2026. The RSUs vest over 3 years, with 40% after the first year, 40% after the second, and 20% after the third. Stock options have an exercise price of $69.31, vesting over 4 years with monthly installments after the first year. The company focuses on cardiovascular treatments, including MYQORZO® (aficamten) for hypertrophic cardiomy...
09-17 20:00
Lepermislibre to Brief Investors as Capital Increase Progresses
Lepermislibre SA ( ($FR:ALLPL) ) has shared an update. Lepermislibre SA, the Fr...
09-17 15:22
Linkage Global Inc Announces 23 for 1 Share Consolidation
Linkage Global Inc. shareholders approved a 23-for-1 share consolidation to comply with Nasdaq listing rules. Effective September 21, 2026, the Class A shares will trade under the same symbol "UZX" but with a new CUSIP number. Each 23 shares will convert to one share, with no fractional shares issued. The authorized and outstanding shares will be reduced accordingly, and the par value will increase to $0.0575 per share. The company aims to mainta...
09-17 10:30
Viant Technology launches 8.5M-share sale: Key details here
Viant Technology (DSP) launched an underwritten public offering of 8.5M Class A shares by a selling stockholder on Wednesday. The underwriters have a 30-day option to purchase up to 1.28M additional s...
09-17 05:57
Vicor licenses VPD to a leading AI OEM
Vicor授予一家新OEM供应商非排他性许可，允许其从未经许可的供应商处采购受专利保护的Vertical Power Delivery (VPD)模块。VPD技术通过高电流密度和低电压源为高性能AI计算和网络处理器提供动力，解决了传统Lateral Power Delivery (LPD)的“最后一英寸问题”。Vicor的VPD系统采用多层结构，包含“多单元转换器”和VPD网络，通过基础专利保护其创新。Vicor还提供多源采购灵活性，包括从其美国工厂采购模块，以实现供应链冗余和可扩展性。未获许可的OEM和超大规模企业可能需要获得许可以保障供应链，早期采用者可享受较低的版税。
09-16 20:00
Praj and Gevo Forge Landmark Alliance to Advance Bio-IBA in India
Praj Industries and Gevo, Inc. have signed a Development & Commercialization Agreement to advance Bio-Isobutanol (Bio-IBA) technology in India, targeting sustainable low-carbon fuel solutions. Under the agreement, Praj will lead Bio-IBA's commercialization, focusing on diesel blending to reduce carbon intensity. The partnership leverages Praj's expertise in engineering and market development with Gevo's Bio-IBA technology. A demonstration plant i...
09-16 13:00
Li Auto Inc. Launches Li i9, a Pioneering Flagship Family SUV
Li Auto Inc. has officially launched its flagship family SUV, the Li i9, priced at RMB 369,800 for the standard configuration, with deliveries set to begin this week. The company, a leader in China's new energy vehicle market, focuses on premium smart electric vehicles and aims to provide safe, convenient, and comfortable products for families. Li Auto is expanding its product lineup to target a broader user base while advancing in extended-range...
09-16 13:00
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results
NeOnc Technologies Holdings, Inc. CEO Amir Heshmatpour and other executives have purchased significant shares in the company following positive Phase 2a results for NEO100™. Heshmatpour bought 111,000 shares for approximately $418,700, while CMO Thomas Chen purchased 49,016 shares for about $210,000. The Phase 2a study met its primary endpoint with a 48.9% six-month progression-free survival rate, and the company's NEO212 program has completed Ph...
09-16 12:00
